Silexion Therapeutics (SLXN) Enterprise Value (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Enterprise Value of -$2.4 million for Q1 2026, up 60.78% year-over-year from -$1.5 million in Q1 2025, and down 8837.04% quarter-over-quarter from -$27000.0 in Q4 2025.
Silexion Therapeutics (SLXN) Enterprise Value (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Enterprise Value history runs 4 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 60.78% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$2.4 million (up 60.78% YoY), while the FY2025 annual figure was -$27000.0, up 97.73% from the prior year.
- Enterprise Value for Q1 2026 stood at -$2.4 million, down from -$27000.0 in the prior quarter.
- The five-year high for Enterprise Value was $1.6 million in Q2 2024, with the low at -$9.2 million in Q3 2025.
- The 4-year median for Enterprise Value is -$2.6 million (2024), against an average of -$3.3 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 125.32% in 2024, then tumbled 368.47% in 2025.
- Silexion Therapeutics' Enterprise Value stood at -$1.2 million in 2023, then gained by 1.08% to -$1.2 million in 2024, then jumped by 97.73% to -$27000.0 in 2025, then tumbled by 8837.04% to -$2.4 million in 2026.
- Business Quant data shows SLXN's Enterprise Value at -$2.4 million in Q1 2026, -$27000.0 in Q4 2025, and -$9.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | -2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.23 Mn |
| Mar 31, 2026 | -2.41 Mn |
| Dec 31, 2025 | -27,000.00 |
| Sep 30, 2025 | -9.24 Mn |
| Jun 30, 2025 | -3.47 Mn |
| Mar 31, 2025 | -6.15 Mn |
| Dec 31, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Jun 30, 2023 | -6.44 Mn |